US stocks bounce ahead of Fed meeting
4:10pm: Stocks slump on Fed decision Both the S&P 500 and the Dow lost ground at the close Wednesday as investors weighed the Fed's decision to hold off on...
Source: proactiveinvestors.com
Page 2 - Psygen Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psygen Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Psygen Labs Today - Breaking & Trending Today
US stocks retreat at the close as investors weigh Fed decision to hold rates
4:10pm: Stocks slump on Fed decision Both the S&P 500 and the Dow lost ground at the close Wednesday as investors weighed the Fed's decision to hold off on...
Source: proactiveinvestors.com
Universal Ibogaine takes big step forward entering into drug supply agreement
Universal Ibogaine CEO Nick Karos joined Steve Darling from Proactive to share news the company has entered into an agreement with Psygen Labs to secure a...
Source: proactiveinvestors.com
Take Two Shrooms and Call Me in the Morning: The Medical Promise of Magic Mushrooms
Psilocybin can treat depression, alcoholism, PTSD, and even cluster headaches. Why is it still illegal?
Source: thewalrus.ca
Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments
Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments "Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides an update on license amendments issued to its clinical research organization, The Centre for Human Drug Research (CHDR). Entheon confirms that the CHDR, the Company's Netherlands-based partner clinical research organization, has received an amendment to its opioid license, enabling it to possess and conduct research with DMT. The opioid license amendment ...
Source: finanznachrichten.de